19-12657482-G-C
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000528.4(MAN2B1):āc.1383C>Gā(p.Tyr461*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000707 in 1,414,556 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000528.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAN2B1 | NM_000528.4 | c.1383C>G | p.Tyr461* | stop_gained | 11/24 | ENST00000456935.7 | NP_000519.2 | |
MAN2B1 | NM_001173498.2 | c.1380C>G | p.Tyr460* | stop_gained | 11/24 | NP_001166969.1 | ||
MAN2B1 | XM_005259913.3 | c.1386C>G | p.Tyr462* | stop_gained | 11/24 | XP_005259970.1 | ||
MAN2B1 | XM_047438841.1 | c.282C>G | p.Tyr94* | stop_gained | 4/17 | XP_047294797.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAN2B1 | ENST00000456935.7 | c.1383C>G | p.Tyr461* | stop_gained | 11/24 | 1 | NM_000528.4 | ENSP00000395473.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 7.07e-7 AC: 1AN: 1414556Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 699720
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Deficiency of alpha-mannosidase Pathogenic:6
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | This sequence change creates a premature translational stop signal (p.Tyr461*) in the MAN2B1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MAN2B1 are known to be pathogenic (PMID: 9915946, 22161967). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with alpha-mannosidosis (PMID: 17979865). ClinVar contains an entry for this variant (Variation ID: 189068). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Baylor Genetics | Oct 03, 2014 | Our laboratory reported dual molecular diagnoses in SCN8A (NM_014191.3, c.647T>G) and MAN2B1 (NM_000528.3, c.2782G>C and c.1383C>G in trans) in one individual with reported features that include delayed motor milestones, delayed speech, intellectual disability, hypotonia, seizure disorder (refractory epilepsy), abnormal movements (dyskinesia), minor dysmorphic features (flat nasal bridge, prominent eyes, full lips), microcephaly, dysphagia, and cortical visual impairment. The c.1383C>G variant in MAN2B1 has been previously reported as disease-causing [PMID 17979865]. - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 04, 2016 | Variant summary: The MAN2B1 c.1383C>G (p.Tyr461X) variant results in a premature termination codon, predicted to cause a truncated or absent MAN2B1 protein due to nonsense mediated decay, which are commonly known mechanisms for disease. One in silico tool predicts a damaging outcome for this variant. This variant was absent in 17720 control chromosomes, but has been observed in at least one alpha-mannosidosis patient in homozygous state. In addition, one clinical diagnostic laboratory classified this variant as likely pathogenic, and a similar variant, c.1383C>A (p.Y461X), was classified as pathogenic by Emory Genetics. c.1383C>A (p.Y461X) has been reported in multiple alpha-mannosidosis patients (PMID: 22161967). Taken together, this variant is classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | literature only | Counsyl | Nov 25, 2014 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | May 25, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at